COVID-19 and Coinfections: A Serious Health Threat Requires Combination of Diagnosis and Therapy

Overview

Journal Infect Disord Drug Targets

Publisher Bentham Science Publishers

Specialty Infectious Diseases

Date 2022 Apr 7

PMID 35388765

Authors

Shahid Nawaz

Maira Saleem

Affiliations

Soon will be listed here.

Abstract

Since the advent of the COVID-19 pandemic in 2019, a mammoth research activity targeting the etiological features of COVID-19 has commenced. Many aspects of the disease have been studied, and various others are under consideration. The secondary microbial coinfections with COVID-19 have generated some serious concerns across the globe. This review mainly focuses on the notable secondary coinfections. The coinfection of influenza, tuberculosis, and typhoid may mimic the original COVID-19 symptoms. Physicians and clinicians must focus on the secondary coinfections which may aggravate the disease progression towards acute respiratory disorder syndrome (ARDS). Diagnostic strategies must also be redefined to determine the actual underlying secondary coinfection. There is a need for combination therapy and diagnostic approaches to minimize the risks associated with the COVID-19 pandemic effectively.

References

Wu Y, Chen C, Chan Y . The outbreak of COVID-19: An overview. J Chin Med Assoc. 2020; 83(3):217-220. PMC: 7153464. DOI: 10.1097/JCMA.0000000000000270. View

Machado B, Hodel K, Barbosa-Junior V, Soares M, Badaro R . The Main Molecular and Serological Methods for Diagnosing COVID-19: An Overview Based on the Literature. Viruses. 2021; 13(1). PMC: 7823618. DOI: 10.3390/v13010040. View

Long Q, Tang X, Shi Q, Li Q, Deng H, Yuan J . Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nat Med. 2020; 26(8):1200-1204. DOI: 10.1038/s41591-020-0965-6. View

Nawaz S . COVID-19, SARS -CoV-2, Origin, Transmission and Treatment Aspects, A Brief Review. Infect Disord Drug Targets. 2020; 21(5):e270421186673. DOI: 10.2174/1871526520666201006163641. View

Shereen M, Khan S, Kazmi A, Bashir N, Siddique R . COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses. J Adv Res. 2020; 24:91-98. PMC: 7113610. DOI: 10.1016/j.jare.2020.03.005. View

Li R, Pei S, Chen B, Song Y, Zhang T, Yang W . Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2). Science. 2020; 368(6490):489-493. PMC: 7164387. DOI: 10.1126/science.abb3221. View

Lai C, Wang C, Hsueh P . Co-infections among patients with COVID-19: The need for combination therapy with non-anti-SARS-CoV-2 agents?. J Microbiol Immunol Infect. 2020; 53(4):505-512. PMC: 7245213. DOI: 10.1016/j.jmii.2020.05.013. View

Kalantar-Zadeh K, Ward S, Kalantar-Zadeh K, El-Omar E . Considering the Effects of Microbiome and Diet on SARS-CoV-2 Infection: Nanotechnology Roles. ACS Nano. 2020; 14(5):5179-5182. DOI: 10.1021/acsnano.0c03402. View

Rana M, Usman M, Alam M, Ikram A, Salman M . Overlapping clinical manifestations of COVID-19 with endemic infectious diseases in Pakistan: A looming threat of multiple lethal combinations. Infect Ecol Epidemiol. 2021; 11(1):1873494. PMC: 7832986. DOI: 10.1080/20008686.2021.1873494. View

10.

Salehi M, Ahmadikia K, Mahmoudi S, Kalantari S, Jamalimoghadamsiahkali S, Izadi A . Oropharyngeal candidiasis in hospitalised COVID-19 patients from Iran: Species identification and antifungal susceptibility pattern. Mycoses. 2020; 63(8):771-778. PMC: 7361944. DOI: 10.1111/myc.13137. View

11.

Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y . Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020; 395(10223):507-513. PMC: 7135076. DOI: 10.1016/S0140-6736(20)30211-7. View

12.

Haqqi A, Awan U, Ali M, Saqib M, Ahmed H, Afzal M . COVID-19 and dengue virus coepidemics in Pakistan: A dangerous combination for an overburdened healthcare system. J Med Virol. 2020; 93(1):80-82. PMC: 7300443. DOI: 10.1002/jmv.26144. View

13.

Ahmad S, Tsagkaris C, Aborode A, Haque M, Khan S, Khawaja U . A skeleton in the closet: The implications of COVID-19 on XDR strain of typhoid in Pakistan. Public Health Pract (Oxf). 2021; 2:100084. PMC: 7826057. DOI: 10.1016/j.puhip.2021.100084. View

14.

Wang J, Cui H, Tang H, Deng X . Gastrointestinal symptoms and fecal nucleic acid testing of children with 2019 coronavirus disease: a systematic review and meta-analysis. Sci Rep. 2020; 10(1):17846. PMC: 7576139. DOI: 10.1038/s41598-020-74913-0. View

15.

Ge H, Wang X, Yuan X, Xiao G, Wang C, Deng T . The epidemiology and clinical information about COVID-19. Eur J Clin Microbiol Infect Dis. 2020; 39(6):1011-1019. PMC: 7154215. DOI: 10.1007/s10096-020-03874-z. View

16.

Ma S, Lai X, Chen Z, Tu S, Qin K . Clinical characteristics of critically ill patients co-infected with SARS-CoV-2 and the influenza virus in Wuhan, China. Int J Infect Dis. 2020; 96:683-687. PMC: 7250072. DOI: 10.1016/j.ijid.2020.05.068. View

17.

Khorramdelazad H, Kazemi M, Najafi A, Keykhaee M, Zolfaghari Emameh R, Falak R . Immunopathological similarities between COVID-19 and influenza: Investigating the consequences of Co-infection. Microb Pathog. 2020; 152:104554. PMC: 7607235. DOI: 10.1016/j.micpath.2020.104554. View

18.

Marin-Hernandez D, Schwartz R, Nixon D . Epidemiological evidence for association between higher influenza vaccine uptake in the elderly and lower COVID-19 deaths in Italy. J Med Virol. 2020; 93(1):64-65. PMC: 7300995. DOI: 10.1002/jmv.26120. View

19.

Min J, Jang Y . Macrolide therapy in respiratory viral infections. Mediators Inflamm. 2012; 2012:649570. PMC: 3375106. DOI: 10.1155/2012/649570. View

20.

Ohe M, Shida H, Jodo S, Kusunoki Y, Seki M, Furuya K . Macrolide treatment for COVID-19: Will this be the way forward?. Biosci Trends. 2020; 14(2):159-160. DOI: 10.5582/bst.2020.03058. View